Market By Device Type And Geography | Forecast 2021-2028
Triton Market Research predicts that the global peripheral vascular devices market would rise with a CAGR of 11.54% during the forecast period 2021-2028. It was valued at $2771.43 million in the year 2020, and is expected to gain a revenue of about $7414.83 million by the year 2028.
Peripheral vascular disease is a condition that causes blood vessels located outside the heart and brain to get blocked. PVD occurs when plaque builds up in arteries that carry blood to the organs, head, and limbs. Plaque is made of cholesterol, fibrous tissue, fat, calcium, and other substances.
Triton Market Research’s report on the peripheral vascular devices market provides an in-depth insight into this industry. The detailed analysis of the market includes key market insights, Porter’s five forces analysis, and market attractiveness index. Â
Factors such as minimally-invasive procedures for peripheral arterial disease, the proliferating incidence of peripheral arterial disease, changing lifestyle, rapid growth in the aging population, and continuous technological advancements are expected to foster the growth of the market during the forecast period. Junk food, lack of proper sleep, lack of exercise, and smoking addiction are the most common habits seen in most people.
However, these habits become dangerous as time passes, and people suffer from different conditions associated with peripheral vascular disease (PVD). The acceptance of a fast-moving and unhealthy lifestyle is a factor that lands people into surgeries related to PVD. In addition, the rising aging population is also responsible for the increasing number of cases of PAD. As PAD is one of the common diseases that come with aging, a rise in the number of aging people is likely to contribute to the increasing incidence of these diseases, and ultimately drive the market studied.
Furthermore, awareness in patients about treatment options and market potential in developing countries are expected to act as some opportunities for the market. Awareness in patients about treatment options for cardiac disorders plays a vital role in the growth of the market. To treat cardiac disorders among patients, doctors & other healthcare providers, along with governments and key players in the industry, have initiated several programs to increase the awareness level.
Reimbursement is given for peripheral vascular diseases, but the problem associated with reimbursement policies is that coverage is given to only specific therapies. Most of the time, it is only given for the surgery and not for other therapies and rehabilitation. This ultimately affects the number of people opting for rehabilitation in the office of a doctor and as they may choose to do it on their own. Furthermore, stringent regulatory processes and intense competition are some of the key restraining factors of the peripheral vascular devices market.
Key geographies covered in the global peripheral vascular devices market are:
•          North America: United States and Canada
•          Europe: United Kingdom, France, Germany, Spain, Italy, Russia, and Rest of Europe
•          Asia-Pacific: China, Japan, India, Australia & New Zealand, South Korea, ASEAN Countries, and Rest of Asia-Pacific
•          Latin America: Brazil, Mexico, and Rest of Latin America
•          Middle East and Africa: Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle East & Africa
The segmentation analysis of the peripheral vascular devices market includes device type.
Device Type is sub-segmented into:
•          Market by Device Type:    Â
o         Peripheral Vascular Stents:         Â
•          Self-expanding Peripheral Vascular Stents      Â
•          Balloon-expanding Peripheral Vascular StentsÂ
•          Drug-eluting Peripheral Vascular Stents
•          Covered Stents      Â
o         Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters:  Â
•          Standard PTA Balloon Catheter  Â
•          High-Pressure PTA Balloon Catheter    Â
•          Large PTA Balloon Catheter        Â
•          Small PTA Balloon Catheter        Â
•          Specialty PTA Balloon Catheter  Â
•          Drug-coated PTA Balloon Catheter        Â
o         Percutaneous Transluminal Angioplasty (PTA) Guidewires  Â
o         Atherectomy Devices        Â
o         Embolic Protection Devices         Â
o         Inferior Vena Cava Filters Â
o         Other Device Types
The key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips NV, Cook Group, Becton Dickinson and Company, Cardinal Health Inc (Cordis), Medtronic Plc, Endologix, Angioscore Inc (Spectranetics Corporation), Terumo Interventional Systems Inc, Edwards Lifesciences Corporation, and Teleflex Medical.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET - SUMMARYÂ
2. INDUSTRY OUTLOOKÂ Â
2.1. KEY INSIGHTSÂ Â Â Â Â Â
2.1.1. SURGE IN THE ADOPTION OF VASCULAR PROCEDURESÂ Â Â Â Â Â Â Â Â Â
2.1.2. PRODUCT RECALLS OWING TO SAFETY CONCERNSÂ Â Â Â Â Â
2.2. IMPACT OF COVID-19 ON PERIPHERAL VASCULAR DEVICES MARKETÂ Â Â Â Â Â Â
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTSÂ Â Â Â
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERSÂ Â Â Â Â Â
2.3.5. THREAT OF COMPETITIVE RIVALRYÂ Â
2.4. MARKET ATTRACTIVENESS INDEXÂ Â
2.5. VENDOR SCORECARDÂ
2.6. KEY MARKET STRATEGIESÂ Â Â Â Â
2.6.1. MERGER & ACQUISITIONSÂ Â Â Â Â Â Â Â Â
2.6.2. PRODUCT LAUNCH & DEVELOPMENTSÂ Â Â Â Â Â Â Â
2.6.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATIONÂ Â
2.6.4. BUSINESS EXPANSIONÂ Â Â
2.7. MARKET DRIVERSÂ Â Â Â Â Â Â Â Â
2.7.1. MINIMALLY-INVASIVE PROCEDURES FOR PERIPHERAL ARTERIAL DISEASEÂ Â Â
2.7.2. PROLIFERATING INCIDENCE OF PERIPHERAL ARTERIAL DISEASEÂ Â Â Â
2.7.3. CHANGING LIFESTYLE AND RAPID GROWTHÂ IN AGING POPULATIONÂ Â Â Â Â Â Â Â Â Â Â
2.7.4. CONTINUOUS TECHNOLOGICAL ADVANCEMENTS
2.8. MARKET RESTRAINTSÂ Â
2.8.1. STRINGENT REGULATORY PROCESS
2.8.2. LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICESÂ Â Â Â Â Â Â Â Â
2.8.3. INTENSE COMPETITIONÂ Â
2.9. MARKET OPPORTUNITIESÂ Â Â Â Â Â Â
2.9.1. AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONSÂ Â Â Â Â Â Â Â Â Â
2.9.2. MARKET POTENTIAL IN DEVELOPING COUNTRIESÂ Â Â Â Â Â Â Â Â Â Â
3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET OUTLOOK – BY DEVICE TYPE  Â
3.1. PERIPHERAL VASCULAR STENTSÂ Â Â Â
3.1.1. SELF-EXPANDING PERIPHERAL VASCULAR STENTSÂ Â Â Â Â Â
3.1.2. BALLOON-EXPANDING PERIPHERAL VASCULAR STENTSÂ Â Â Â Â Â Â Â Â Â
3.1.3. DRUG-ELUTING PERIPHERAL VASCULAR STENTS
3.1.4. COVERED STENTS
3.2. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERSÂ
3.2.1. STANDARD PTA BALLOON CATHETERÂ Â Â Â Â Â Â Â Â Â
3.2.2. HIGH-PRESSURE PTA BALLOON CATHETERÂ Â Â Â Â Â Â Â Â Â Â
3.2.3. LARGE PTA BALLOON CATHETERÂ Â Â Â Â Â Â
3.2.4. SMALL PTA BALLOON CATHETERÂ Â Â Â Â Â Â
3.2.5. SPECIALTY PTA BALLOON CATHETERÂ Â Â Â Â Â Â Â Â Â
3.2.6. DRUG-COATED PTA BALLOON CATHETERÂ Â
3.3. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRESÂ Â Â Â Â Â Â Â
3.4. ATHERECTOMY DEVICESÂ Â Â Â Â Â Â Â
3.5. EMBOLIC PROTECTION DEVICESÂ Â Â Â Â
3.6. INFERIOR VENA CAVA FILTERSÂ Â Â Â Â Â Â Â Â
3.7. OTHER DEVICE TYPESÂ
4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET – REGIONAL OUTLOOK   Â
4.1. NORTH AMERICA
4.1.1.  MARKET BY DEVICE TYPE       Â
4.1.1.1. MARKET BY PERIPHERAL VASCULAR STENTSÂ Â Â Â Â Â Â Â Â
4.1.1.2. MARKET BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERSÂ Â Â Â Â Â Â Â Â Â
4.1.2.  COUNTRY ANALYSIS     Â
4.1.2.1. UNITED STATESÂ Â Â Â Â Â Â
4.1.2.2. CANADAÂ Â Â Â Â Â Â Â Â
4.2. EUROPEÂ Â Â Â
4.2.1.  MARKET BY DEVICE TYPE       Â
4.2.1.1. MARKET BY PERIPHERAL VASCULAR STENTSÂ Â Â Â Â Â Â Â Â
4.2.1.2. MARKET BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERSÂ Â Â Â Â Â Â Â Â Â
4.2.2.  COUNTRY ANALYSIS     Â
4.2.2.1. UNITED KINGDOMÂ Â Â Â
4.2.2.2. GERMANYÂ Â Â Â Â Â
4.2.2.3. FRANCEÂ Â Â Â Â Â Â Â Â Â
4.2.2.4. SPAINÂ Â
4.2.2.5. ITALYÂ Â Â Â
4.2.2.6. RUSSIA
4.2.2.7. REST OF EUROPEÂ Â Â
4.3. ASIA-PACIFICÂ Â Â Â Â Â Â
4.3.1.  MARKET BY DEVICE TYPE       Â
4.3.1.1. MARKET BY PERIPHERAL VASCULAR STENTSÂ Â Â Â Â Â Â Â Â
4.3.1.2. MARKET BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERSÂ Â Â Â Â Â Â Â Â Â
4.3.2.  COUNTRY ANALYSIS     Â
4.3.2.1. CHINAÂ Â
4.3.2.2. JAPANÂ
4.3.2.3. INDIAÂ Â Â Â
4.3.2.4. SOUTH KOREAÂ Â Â Â Â Â Â Â Â
4.3.2.5. ASEAN COUNTRIES
4.3.2.6. AUSTRALIA & NEW ZEALANDÂ Â Â Â Â Â
4.3.2.7. REST OF ASIA-PACIFICÂ Â Â Â Â Â
4.4. LATIN AMERICAÂ Â
4.4.1.  MARKET BY DEVICE TYPE       Â
4.4.1.1. MARKET BY PERIPHERAL VASCULAR STENTSÂ Â Â Â Â Â Â Â Â
4.4.1.2. MARKET BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERSÂ Â Â Â Â Â Â Â Â Â
4.4.2.  COUNTRY ANALYSIS     Â
4.4.2.1. BRAZIL
4.4.2.2. MEXICOÂ Â Â Â Â Â Â Â Â Â Â
4.4.2.3. REST OF LATIN AMERICAÂ
4.5. MIDDLE EAST AND AFRICAÂ Â Â Â Â
4.5.1.  MARKET BY DEVICE TYPE       Â
4.5.2.  MARKET BY PERIPHERAL VASCULAR STENTS     Â
4.5.3.  MARKET BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS Â
4.5.4.  COUNTRY ANALYSIS     Â
4.5.4.1. UNITED ARAB EMIRATESÂ Â
4.5.4.2. TURKEYÂ Â Â Â Â Â Â Â Â Â
4.5.4.3. SAUDI ARABIAÂ Â Â Â Â Â Â Â Â Â
4.5.4.4. SOUTH AFRICAÂ Â Â Â Â Â Â Â Â
4.5.4.5. REST OF MIDDLE EAST & AFRICAÂ Â Â Â Â Â Â Â Â Â
5. COMPETITIVE LANDSCAPEÂ
5.1. ABBOTT LABORATORIESÂ Â Â Â Â Â Â Â Â
5.2. ANGIOSCORE INC (SPECTRANETICS CORPORATION)Â Â
5.3. BOSTON SCIENTIFIC CORPORATIONÂ Â Â Â Â Â Â Â Â Â
5.4. BECTON DICKINSON AND COMPANYÂ Â Â Â Â Â Â Â Â Â
5.5. COOK GROUPÂ Â Â Â Â Â
5.6. CARDINAL HEALTH INC (CORDIS)Â Â Â Â Â
5.7. EDWARDS LIFESCIENCES CORPORATION
5.8. ENDOLOGIXÂ Â Â Â Â Â Â Â Â Â
5.9. KONINKLIJKE PHILIPS NV
5.10. MEDTRONIC PLCÂ Â Â Â Â Â Â Â Â Â
5.11. TELEFLEX MEDICALÂ Â Â Â
5.12. TERUMO INTERVENTIONAL SYSTEMS INCÂ Â Â Â Â Â Â Â Â Â
6. METHODOLOGY & SCOPEÂ Â Â Â
6.1. RESEARCH SCOPE & DELIVERABLESÂ Â Â Â Â Â Â Â
6.2. SOURCES OF DATAÂ Â Â Â Â Â Â
6.3. RESEARCH METHODOLOGYÂ Â
TABLE 1: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF MERGER & ACQUISITIONS
TABLE 5: LIST OF PRODUCT LAUNCH & DEVELOPMENTS
TABLE 6: LIST OF PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
TABLE 7: LIST OF BUSINESS EXPANSION
TABLE 8: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
TABLE 14: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 15: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2021-2028 (IN $ MILLION)
TABLE 16: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2021-2028 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
TABLE 22: LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 23: LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2021-2028 (IN $ MILLION)
TABLE 24: LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
TABLE 25: LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
TABLE 26: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 27: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2021-2028 (IN $ MILLION)
TABLE 28: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
TABLE 29: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2020 & 2028
FIGURE 3: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 4: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2020 & 2028
FIGURE 5: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY SELF-EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY BALLOON-EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG-ELUTING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY COVERED STENT, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2020 & 2028
FIGURE 11: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY STANDARD PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY HIGH-PRESSURE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY LARGE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY SMALL PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY SPECIALTY PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG-COATED PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY INFERIOR VENA CAVA FILTERS, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY OTHER DEVICE TYPES, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 23: UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: CANADA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: UNITED KINGDOM PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: GERMANY PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: FRANCE PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: SPAIN PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: ITALY PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: RUSSIA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: REST OF EUROPE PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: CHINA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: JAPAN PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: INDIA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: SOUTH KOREA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: ASEAN COUNTRIES PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: AUSTRALIA & NEW ZEALAND PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: REST OF ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: BRAZIL PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 40: MEXICO PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: REST OF LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: UNITED ARAB EMIRATES PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: TURKEY PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 44: SAUDI ARABIA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: SOUTH AFRICA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: REST OF MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)